Inflammatory cascade injury

The inflammatory cascade injury refers to the complex series of cellular and molecular events that the body initiates in response to tissue damage or pathogenic insult[1][5]. This includes the activation of immune cells (neutrophils, macrophages, lymphocytes), release of chemical mediators (cytokines, chemokines, acute phase proteins), and engagement of plasma cascades (complement, kinin, and coagulation systems)[1][5][7]. The cascade leads to classical signs of inflammation—redness, swelling, heat, pain, and functional loss—and ultimately aims to repair tissue damage and restore homeostasis. However, excessive or chronic activation can contribute to further tissue injury and is central to many inflammatory and autoimmune diseases[4][5][7]. Anti-inflammatory therapies, such as NSAIDs and corticosteroids, target various components of this cascade to control or suppress unwanted inflammation[3].

Other names

Inflammatory response cascadeInflammation cascadeImmune cascade injuryInflammatory pathway activation

Inhibition of prostaglandin and cytokine synthesis (e.g., COX inhibition by NSAIDs), suppression of immune cell activation, reduction of inflammatory mediator production.